AstraZeneca Shares Drop After Weak Quarterly Print Despite 2024 Growth Guidance -- 2nd Update

By Elena Vardon AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it...

Related Keywords

Sweden ,London ,City Of ,United Kingdom ,Swedish ,Pascal Soriot ,Elena Vardon ,Astrazeneca ,Executive Pascal Soriot ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Financial Performance ,Earnings ,Share Price Movement Disruptions ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Azn Ln ,Uk Azn ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,